Skip to content
20-F

Annual Report (Foreign)

C3is Inc. CISS

0001193125-25-100539

← back to feed
Filed
Apr 28, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding restated FY 2024 · Dec 31, 2023 5.83K sh
Cash And Equivalents FY 2024 · Dec 31, 2023 $695.29K
Cash And Equivalents FY 2024 · Oct 18, 2022 $23.5M
Current Liabilities FY 2024 · Dec 31, 2023 $39.93M
Total Liabilities FY 2024 · Dec 31, 2023 $39.93M
Current Assets FY 2024 · Dec 31, 2023 $20.31M
Total Assets FY 2024 · Dec 31, 2023 $95.47M
Shares Diluted restated FY 2024 · Dec 31, 2022 4.98K sh
Capex FY 2024 · Dec 31, 2022 $39.39M
Capex FY 2024 · Oct 18, 2022 $15.98M
Operating Cash Flow FY 2024 · Dec 31, 2022 $1.05M
Operating Cash Flow FY 2024 · Oct 18, 2022 $9.01M
Eps Diluted restated FY 2024 · Dec 31, 2022 $110.78
Eps Basic restated FY 2024 · Dec 31, 2022 $259.94
Net Income FY 2024 · Dec 31, 2022 $551.59K
Net Income FY 2024 · Oct 18, 2022 $17.46M
Operating Income FY 2024 · Dec 31, 2022 $552.06K
Operating Income FY 2024 · Oct 18, 2022 $17.58M
Revenue FY 2024 · Dec 31, 2022 $3.29M
Revenue FY 2024 · Oct 18, 2022 $12.85M
Stockholders Equity FY 2024 · Oct 18, 2022 $42.9M
Stockholders Equity FY 2024 · Jul 24, 2022 $0
Stockholders Equity restated FY 2024 · Mar 11, 2021 $8.75M